Brief: India's Sequent Scientific March-Qtr Consol Profit Falls
14/05/2019 09:10
May 14 (Reuters) - SeQuent Scientific Ltd SEQU.NS :
* MARCH QUARTER CONSOL NET PROFIT 171.2 MILLION RUPEES
VERSUS 4
BILLION RUPEES YEAR AGO
* MARCH QUARTER CONSOL REVENUE FROM OPERATIONS 2.82 BILLION
RUPEES
VERSUS 2.33 BILLION RUPEES YEAR AGO
* RECOMMENDED 0.2 RUPEES DIVIDEND PER SHARE
Source text for Eikon: ID:nBSE1WtN9b
Further company coverage: SEQU.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Viyash Scientific
See all newsBrief: Viyash Scientific Says Bioforlife Italia Acquisition Expected To Complete Within Two Months From Sept 8
Brief: Viyash Scientific Ltd June-Quarter Consol Net Profit 658.7 Million Rupees
Brief: Viyash Scientific's Subsidiary To Buy 100% Of Bioforlife Italia
Brief: Viyash Scientific March-Quarter Consol Net Profit 521.1 Million Rupees
Brief: Viyash Scientific Partners With Boehringer Ingelheim In India